-
Notifications
You must be signed in to change notification settings - Fork 4
Commit
This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository.
Added tests for transcript selection
- Loading branch information
1 parent
d6390fe
commit 422f097
Showing
6 changed files
with
122 additions
and
31 deletions.
There are no files selected for viewing
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1 @@ | ||
{"title":"CCR5 HIV binding","methodText":"Data obtained from sorting cells for both surface expression and HIV-1~BaL~ gp120-CD4 interaction was analysed using Enrich (version unspecified). Log~2~ enrichment ratios were calculated and normalised by subtracting the frequency of the WT sequence. Log~2~ enrichment ratios for two replicates were averaged to obtain variant scores. Note that the scores here were not reported in the manuscript tables, but were calculated from the replicate enrichment ratios that were reported.","abstractText":"This experiment utilised site-saturation mutagenesis (SSM) to measure the functional consequences of mutations in the human chemokine receptor, CCR5 and to map ligand interaction sites. Cells were selected for binding to HIV-1~BaL~ gp120-CD4.","shortDescription":"Deep mutational scan selecting for CCR5 binding to HIV-1(BaL) gp120-CD4 in Expi293F cells.","extraMetadata":{},"urn":"urn:mavedb:00000047-c-1","numVariants":7020,"experiment":{"title":"CCR5 HIV binding","shortDescription":"Deep mutational scan selecting for CCR5 binding to HIV-1(BaL) gp120-CD4 in Expi293F cells.","abstractText":"This experiment utilised site-saturation mutagenesis (SSM) to measure the functional consequences of mutations in the human chemokine receptor, CCR5 and to map ligand interaction sites. Cells were selected for binding to HIV-1~BaL~ gp120-CD4.","methodText":"The CCR5 variant library was generated by overlapping PCR using primers with an NNK codon, as described by Procko et al, 2013 and transfected into human Expi293F cells (a cell line lacking CCR5) using pCEP4.\r\nCCR5 interactions with chemokines (CCL3, CCL4, CCL5) were unable to be characterised by deep mutational scanning. Instead, cells were selected for interaction with an important protein ligand, the HIV-1 Env subunit gp120 following incubation with HIV-1~BaL~ gp120 fused to CD4 domains D1-D2.\r\nSurface expression was measured using anti-myc-Alexa 647.\r\nCell sorting was performed using a BD FACSAria II.\r\nTotal RNA was extracted and PCR-amplified before sequencing by Illumina MiSeq v3 or HiSeq 2500 to quantify variants. \r\nTwo replicate selections were performed.\r\n\r\nRaw data available from GEO under accession [GSE100368](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE100368).","extraMetadata":{},"urn":"urn:mavedb:00000047-c","createdBy":{"orcidId":"0000-0003-1474-605X","firstName":"Alan","lastName":"Rubin"},"modifiedBy":{"orcidId":"0000-0003-1474-605X","firstName":"Alan","lastName":"Rubin"},"creationDate":"2020-11-11","modificationDate":"2020-11-11","publishedDate":"2020-11-11","experimentSetUrn":"urn:mavedb:00000047","scoreSetUrns":["urn:mavedb:00000047-c-1"],"doiIdentifiers":[],"primaryPublicationIdentifiers":[],"secondaryPublicationIdentifiers":[{"identifier":"29678950","id":34,"url":"http://www.ncbi.nlm.nih.gov/pubmed/29678950","referenceHtml":"Heredia JD, <i>et al</i>. Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning. <i>J Immunol</i>. 2018; <b>200</b>:3825-3839."},{"identifier":"23827138","id":35,"url":"http://www.ncbi.nlm.nih.gov/pubmed/23827138","referenceHtml":"Procko E, <i>et al</i>. Computational design of a protein-based enzyme inhibitor. <i>J Mol Biol</i>. 2013; <b>425</b>:3563-75."}],"rawReadIdentifiers":[],"keywords":[]},"license":{"longName":"CC0 (Public domain)","shortName":"CC0","link":"https://creativecommons.org/publicdomain/zero/1.0/","version":"1.0","id":1},"metaAnalyzesScoreSetUrns":[],"metaAnalyzedByScoreSetUrns":[],"doiIdentifiers":[],"primaryPublicationIdentifiers":[{"identifier":"29678950","id":34,"url":"http://www.ncbi.nlm.nih.gov/pubmed/29678950","referenceHtml":"Heredia JD, <i>et al</i>. Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning. <i>J Immunol</i>. 2018; <b>200</b>:3825-3839."}],"secondaryPublicationIdentifiers":[],"publishedDate":"2020-11-11","creationDate":"2020-11-11","modificationDate":"2020-11-11","createdBy":{"orcidId":"0000-0003-1474-605X","firstName":"Alan","lastName":"Rubin"},"modifiedBy":{"orcidId":"0000-0003-1474-605X","firstName":"Alan","lastName":"Rubin"},"targetGene":{"name":"CCR5","category":"Protein coding","externalIdentifiers":[{"identifier":{"dbName":"UniProt","identifier":"P51681","url":"http://purl.uniprot.org/uniprot/P51681"},"offset":1}],"referenceMaps":[{"id":156,"genomeId":5,"targetId":156,"isPrimary":false,"genome":{"shortName":"hg38","organismName":"Homo sapiens","creationDate":"2018-06-22","modificationDate":"2018-06-22","id":5},"creationDate":"2020-11-11","modificationDate":"2020-11-11"}],"wtSequence":{"sequenceType":"dna","sequence":"GATTATCAAGTGTCAAGTCCAATCTATGACATCAATTATTATACATCGGAGCCCTGCCAAAAAATCAATGTGAAGCAAATCGCAGCCCGCCTCCTGCCTCCGCTCTACTCACTGGTGTTCATCTTTGGTTTTGTGGGCAACATGCTGGTCATCCTCATCCTGATAAACTGCAAAAGGCTGAAGAGCATGACTGACATCTACCTGCTCAACCTGGCCATCTCTGACCTGTTTTTCCTTCTTACTGTCCCCTTCTGGGCTCACTATGCTGCCGCCCAGTGGGACTTTGGAAATACAATGTGTCAACTCTTGACAGGGCTCTATTTTATAGGCTTCTTCTCTGGAATCTTCTTCATCATCCTCCTGACAATCGATAGGTACCTGGCTGTCGTCCATGCTGTGTTTGCTTTAAAAGCCAGGACGGTCACCTTTGGGGTGGTGACAAGTGTGATCACTTGGGTGGTGGCTGTGTTTGCGTCTCTCCCAGGAATCATCTTTACCAGATCTCAAAAAGAAGGTCTTCATTACACCTGCAGCTCTCATTTTCCATACAGTCAGTATCAATTCTGGAAGAATTTCCAGACATTAAAGATAGTCATCTTGGGGCTGGTCCTGCCGCTGCTTGTCATGGTCATCTGCTACTCGGGAATCCTAAAAACTCTGCTTCGGTGTCGAAATGAGAAGAAGAGGCACAGGGCTGTGAGGCTTATCTTCACCATCATGATTGTTTATTTTCTCTTCTGGGCTCCCTACAACATTGTCCTTCTCCTGAACACCTTCCAGGAATTCTTTGGCCTGAATAATTGCAGTAGCTCTAACAGGTTGGACCAAGCTATGCAGGTGACAGAGACTCTTGGGATGACGCACTGCTGCATCAACCCCATCATCTATGCCTTTGTCGGGGAGAAGTTCAGAAACTACCTCTTAGTCTTCTTCCAAAAGCACATTGCCAAACGCTTCTGCAAATGCTGTTCTATTTTCCAGCAAGAGGCTCCCGAGCGAGCAAGCTCAGTTTACACCCGATCCACTGGGGAGCAGGAAATATCTGTGGGCTTG"}},"datasetColumns":{"countColumns":[],"scoreColumns":["score","rep1","rep2"]},"keywords":[],"private":false} |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1 @@ | ||
{"title":"BRAF resistance to vemurafenib","methodText":"Log enrichments for the two replicates were calculated and the median enrichment for each amino acid (across all synonymous codons) are reported here.\r\n\r\nOnly a small subset of variants were reported.","abstractText":"To search for possible secondary mutations that that can confer drug resistance in the context of BRAF V600E, the authors performed a deep mutation scan of human BRAF, selecting for enrichment in B3/F cells surviving vemurafenib treatment.","shortDescription":"Deep mutational scan of the BRAF V600E allele for resistance to the cancer drug vemurafenib.","extraMetadata":{},"urn":"urn:mavedb:00000091-a-1","numVariants":73,"experiment":{"title":"BRAF resistance to vemurafenib","shortDescription":"Deep mutational scan of the BRAF V600E allele for resistance to the cancer drug vemurafenib.","abstractText":"To search for possible secondary mutations that that can confer drug resistance in the context of BRAF V600E, the authors performed a deep mutation scan of human BRAF, selecting for enrichment in B3/F cells surviving vemurafenib treatment.","methodText":"Saturation mutagenesis of 77 amino acids surrounding the PLX4720‐binding site. Eight mutant pools were generated—corresponding to amino acids 458–466, 467–476, 477–486, 501–510, 511–520, 527–536, 579–587, and 588–596—in which each amino acid was mutated to all possible 64 codons. The mutant pools were transferred into a retroviral vector containing BRAFV600E and then stably transduced into the human melanoma cell line A375.\r\n\r\nAfter transfection with mutant BRAF, cells were treated with vemurafenib. Cells surviving vemurafenib treatment were then sequenced to determine the enrichment of resistance mutations.","extraMetadata":{},"urn":"urn:mavedb:00000091-a","createdBy":{"orcidId":"0000-0003-1474-605X","firstName":"Alan","lastName":"Rubin"},"modifiedBy":{"orcidId":"0000-0003-1474-605X","firstName":"Alan","lastName":"Rubin"},"creationDate":"2021-11-13","modificationDate":"2021-11-13","publishedDate":"2021-11-13","experimentSetUrn":"urn:mavedb:00000091","scoreSetUrns":["urn:mavedb:00000091-a-1"],"doiIdentifiers":[],"primaryPublicationIdentifiers":[{"identifier":"24112705","id":71,"url":"http://www.ncbi.nlm.nih.gov/pubmed/24112705","referenceHtml":"Wagenaar TR, <i>et al</i>. Resistance to vemurafenib resulting from a novel mutation in the BRAFV600E kinase domain. Resistance to vemurafenib resulting from a novel mutation in the BRAFV600E kinase domain. 2014; 27:124-33. doi: 10.1111/pcmr.12171"}],"secondaryPublicationIdentifiers":[],"rawReadIdentifiers":[],"keywords":[]},"license":{"longName":"CC0 (Public domain)","shortName":"CC0","link":"https://creativecommons.org/publicdomain/zero/1.0/","version":"1.0","id":1},"metaAnalyzesScoreSetUrns":[],"metaAnalyzedByScoreSetUrns":[],"doiIdentifiers":[],"primaryPublicationIdentifiers":[{"identifier":"24112705","id":71,"url":"http://www.ncbi.nlm.nih.gov/pubmed/24112705","referenceHtml":"Wagenaar TR, <i>et al</i>. Resistance to vemurafenib resulting from a novel mutation in the BRAFV600E kinase domain. Resistance to vemurafenib resulting from a novel mutation in the BRAFV600E kinase domain. 2014; 27:124-33. doi: 10.1111/pcmr.12171"}],"secondaryPublicationIdentifiers":[],"publishedDate":"2021-11-13","creationDate":"2021-11-13","modificationDate":"2021-11-13","createdBy":{"orcidId":"0000-0003-1474-605X","firstName":"Alan","lastName":"Rubin"},"modifiedBy":{"orcidId":"0000-0003-1474-605X","firstName":"Alan","lastName":"Rubin"},"targetGene":{"name":"BRAF","category":"Protein coding","externalIdentifiers":[{"identifier":{"dbName":"UniProt","identifier":"P15056","url":"http://purl.uniprot.org/uniprot/P15056"},"offset":476}],"referenceMaps":[{"id":283,"genomeId":4,"targetId":283,"isPrimary":false,"genome":{"shortName":"hg19","organismName":"Homo sapiens","creationDate":"2018-06-22","modificationDate":"2018-06-22","id":4},"creationDate":"2021-11-13","modificationDate":"2021-11-13"}],"wtSequence":{"sequenceType":"protein","sequence":"HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDF"}},"datasetColumns":{"countColumns":[],"scoreColumns":["score"]},"keywords":[],"private":false} |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters